NovaBridge Biosciences
(NASDAQ) NBP
NovaBridge Biosciences Financials at a Glance
Market Cap
$173.07M
Revenue (TTM)
$0.00
Net Income (TTM)
-$19.88M
EPS (TTM)
-$0.44
P/E Ratio
-3.39
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$1.51
Volume
649,324.332
Open
$1.58
Price
$1.51
Volume
649,324.332
Open
$1.58
Previous Close
$1.50
Daily Range
$1.48 - $1.62
52-Week Range
$1.46 - $6.79
Estimated Earnings Date
Jun 30, 2026
Dividend
$0.00
Beta (Volatility)
1.31 (Average)
Price
$1.51
Volume
649,324.332
Open
$1.58
Previous Close
$1.50
Daily Range
$1.48 - $1.62
52-Week Range
$1.46 - $6.79
Estimated Earnings Date
Jun 30, 2026
NBP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout NovaBridge Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
30
CEO
Xi-Yong Fu, PhD, MBA
Website
www.i-mabbiopharma.comHeadquarters
Rockville, MD 20850, US
NBP Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-95%
Return on Assets
-53%
Earnings Yield
-29.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$173.07M
Shares Outstanding
115.38M
Volume
649.32K
Avg. Volume
890.40K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$13.48M
EBITDA
-$13.35M
Operating Cash Flow
-$20.60M
Capital Expenditure
-$7.00K
Free Cash Flow
-$20.60M
Cash & ST Invst.
$30.14M
Total Debt
$438.46K
NovaBridge Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$173.07M
N/A
Market Cap/Employee
$5.41M
N/A
Employees
32
N/A
Net Income
-$4.40M
+51.4%
EBITDA
-$10.39M
+14.1%
Quarterly Fundamentals
Total Cash
$30.14M
-97.6%
Total Debt
$438.46K
-98.5%
Accounts Receivable
$256.33K
-97.0%
Inventory
$0.00
N/A
Long Term Debt
$311.08K
-98.6%
Short Term Debt
$127.38K
-97.9%
Return on Assets
-53.39%
N/A
Return on Invested Capital
-95.18%
N/A
Free Cash Flow
-$14.60M
N/A
Operating Cash Flow
-$14.60M
N/A